Thank you very much, Mr. Calkins, for being here today.
I want to use my time to understand what problem this bill is trying to solve and also what protections we would be giving up in the process.
First, just to focus on something we've heard throughout this discussion about the risk associated with natural health products, some of the testimony we have heard has left the impression that these products are essentially risk-free—that because we're talking about vitamins and supplements rather than prescription drugs, the safety concerns are somehow theoretical or non-existent. In fact, we've had witnesses put on the record that there are no risks associated with some of these products, which is not accurate.
I absolutely recognize that natural health products are generally lower-risk products. They're not prescription pharmaceuticals, and I don't think anyone is suggesting that they should be regulated in the same way, but I do think that it's important for everyone to understand that lower risk does not mean no risk. We have Canadian examples of products that have been contaminated with lead and of labels that have not accurately reflected what was in the product, and people have experienced serious adverse reactions.
There is also the fact that risk doesn't come solely from something being wrong with the product itself. A product can be manufactured exactly as intended and still interact with another medication. On Monday, we were discussing the example of St. John's wort and the various interactions that can happen.
If we accept that natural health products can cause adverse reactions, can have clinically significant interactions with prescription medications and, like other products, can sometimes be contaminated, then why would we want fewer tools available to protect Canadians when risks are identified after those products are already on the market?
